Myocardial Reperfusion Injury Clinical Trial
Official title:
ACCELerated Inhibition of Platelet Aggregation, Inflammation and Ischemia-reperfusion Injury by Adjunctive Cilostazol Loading in Patients With Acute Coronary Syndrome
The purpose of this study is to determine whether adjunctive cilostazol loading/maintenance to standard treatment (aspirin, clopidogrel, and statin) is effective in reduction of major adverse cardiovascular events, platelet activation, inflammation and myonecrosis in patients with non-ST-elevation acute coronary syndrome (ACS)undergoing percutaneous coronary intervention (PCI).
In ACS patients, platelet activation, inflammation, and ischemia-reperfusion injury can be closely associated with the risk of post-PCI myonecrosis and ischemic events occurrence. In the ACCEL-AMI (Adjunctive Cilostazol versus high maintenance-dose ClopidogrEL in patients with Acute Myocardial Infarction)study, adjunctive cilostazol increased platelet inhibition compared with double-dose clopidogrel. Meanwhile, statins can reduce the extent of myonecrosis via limiting inflammation and myocardial infarct size by activating phosphatidylinositol-3-kinase (PI3K), ecto-5'-nucleotidase, Akt/endothelial nitric oxide synthase (eNOS), and the downstream effectors inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). Inhibition of PI3K, adenosine receptors, eNOS, iNOS, or COX-2 abrogates the protective effects of statins. In animal study, the combination of low-dose statin with cilostazol synergistically limits infarct size. Multiple studies have shown that cilostazol can influence inflammation and RISK pathway using the similar pathway with statin. This study will be performed to evaluate the role of adjunctive cilostazol in platelet inhibition, inflammation, and myonecrosis compared with standard treatment. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT00989508 -
Myocardial Protection With Perhexiline in Left Ventricular Hypertrophy
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT04570514 -
Optimized Cardioprotection Therapy in Obese Subjects With AMI
|
||
Active, not recruiting |
NCT01857414 -
Effect of RIC on Clinical Outcomes in STEMI Patients Undergoing pPCI
|
N/A | |
Completed |
NCT02342522 -
Effect of Remote Ischaemic Conditioning on Clinical Outcomes in STEMI Patients Undergoing PPCI (CONDI2/ERIC-PPCI)
|
N/A | |
Active, not recruiting |
NCT05462730 -
Pulse Glucocorticoid Therapy in Patients With ST-Segment Elevation Myocardial Infarction
|
Phase 2 | |
Completed |
NCT04397939 -
Myocardial Injury and Major Adverse Outcomes in Patients With COVID-19
|
||
Withdrawn |
NCT02098629 -
Concomitant Milrinone and Esmolol Treatment in Patients With Acute Myocardial Infarction
|
Phase 1/Phase 2 | |
Completed |
NCT00586820 -
Role of Endothelin in Microvascular Dysfunction Following PCI for NSTEMI
|
Phase 2 | |
Completed |
NCT02390674 -
Ciclosporin to Reduce Reperfusion Injury in Primary PCI
|
Phase 2 | |
Completed |
NCT00865722 -
Remote Postconditioning in Patients With Acute Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention (PCI)
|
Phase 2/Phase 3 | |
Recruiting |
NCT01307371 -
Cell Therapy in Diabetic Patients With ST-Segment Elevation Myocardial Infarction(STEMI)
|
Phase 1 | |
Completed |
NCT01379261 -
Efficacy of Endovascular Catheter Cooling Combined With Cold Saline for the Treatment of Acute Myocardial Infarction
|
Phase 2/Phase 3 | |
Completed |
NCT00881686 -
Myocardial Protection With Adenosine Preconditioning
|
Phase 1/Phase 2 | |
Completed |
NCT00484575 -
Inhaled Sevoflurane Compared to Intravenous Sedation Post Coronary Artery Bypass Grafting
|
Phase 1/Phase 2 | |
Recruiting |
NCT03995732 -
Efficacy and Safety Evaluation of PC-SOD for Injection in Reducing Myocardial Reperfusion Injury
|
Phase 2 | |
Recruiting |
NCT05775380 -
The Role of Pioglitazone in Vascular Transcriptional Remodeling
|
Phase 4 | |
Completed |
NCT06450912 -
Wall Strain Index Ratio as a Biomarker for Mechanical Complication of Hemorrhagic Myocardial Infarction
|
||
Completed |
NCT05354648 -
Effects of Hypoxic-hyperoxic Preconditioning in Cardio-surgical Patients
|
N/A | |
Completed |
NCT01601795 -
Sevoflurane and Isoflurane - During Cardiopulmonary Bypass With the MECC System (Minimized Extracorporeal Circuit)
|
Phase 4 | |
Completed |
NCT01483755 -
Delayed Postconditioning
|
Phase 2 |